The use of probability maps to deal with the uncertainties in prostate cancer delineation

Radiotherapy and Oncology

Volumn 94, Issue 2, 2010, Pages 168-172

  Korporaal, Johannes G ^a   van den Berg, Cornelis A T ^a   Groenendaal, Greetje ^a   Moman, Maaike R ^a   van Vulpen, Marco ^a   van der Heide, Uulke A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Dynamic contrast enhanced (DCE) imaging; Probability maps; Prostate cancer; Tumor delineation

Indexed keywords

IODINATED CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ALGORITHMS; BIOPSY; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; IOHEXOL; LOGISTIC MODELS; MALE; MIDDLE AGED; PROBABILITY; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77249138257     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.12.023     Document Type: Article

References (41)

1. Buckley D.L., Roberts C., Parker G.J.M., Logue J.P., and Hutchinson C.E. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - initial experience. Radiology 233 (2004) 709-715
2. Franiel T., Lüdemann L., Rudolph B., et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 43 (2008) 481-487
3. Kozlowski P., Chang S.D., Jones E.C., Berean K.W., Chen H., and Goldenberg S.L. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - correlation with biopsy and histopathology. J Magn Reson Imaging 24 (2006) 108-113
4. van Dorsten F.A., van der Graaf M., Engelbrecht M.R.W., et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20 (2004) 279-287
5. Ocak I., Bernardo M., Metzger G., et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 189 (2007) 849
6. Hara N., Okuizumi M., Kawaguchi M., and Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005) 140-147
7. Fütterer J.J., Heijmink S.W.T.P.J., Scheenen T.W.J., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
8. Ito H., Kamoi K., Yokoyama K., Yamada K., and Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol 76 (2003) 617-624
9. Kim C., Park B., and Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr 30 (2006) 7-11
10. van Vulpen M., van den Berg C., Moman M., and van der Heide U. Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose. Radiother Oncol 93 (2009) 180-184
11. Franiel T., Lüdemann L., Taupitz M., Böhmer D., and Beyersdorff D. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Radiother Oncol 93 (2009) 241-245
12. Kershaw L., Logue J., Hutchinson C., Clarke N., and Buckley D. Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. Radiother Oncol 88 (2008) 127-134
13. Pickett B., Vigneault E., Kurhanewicz J., Verhey L., and Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 44 (1999) 921-929
14. Nederveen A.J., Van der Heide U.A., Hofman P., Welleweerd H., and Lagendijk J.J. Partial boosting of prostate tumours. Radiother Oncol 61 (2001) 117-126
15. Meerleer G.D., Villeirs G., Bral S., et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 75 (2005) 325-333
16. van Lin E.N.J.T., Fütterer J.J., Heijmink S.W.T.P.J., et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 (2006) 291-303
17. Henderson E., Milosevic M.F., Haider M.A., and Yeung I.W.T. Functional CT imaging of prostate cancer. Phys Med Biol 48 (2003) 3085-3100
18. Jeukens C.R.L.P.N., Van den Berg C.A.T., Donker R., et al. Feasibility and measurement precision of 3D quantitative blood flow mapping of the prostate using dynamic contrast-enhanced multi-slice CT. Phys Med Biol 51 (2006) 4329-4343
19. Harvey C., Blomley M., Dawson P., et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr 25 (2001) 43-49
20. Win Z., Ariff B., Harvey C., et al. Comparative study of experienced vs non-experienced radiologists in assessing parametric CT images of the response of the prostate gland to radiotherapy. Br J Radiol 81 (2008) 572-576
21. Klein S., Staring M., Murphy K., Viergever M., and Pluim J. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29 (2010) 196-205
22. Smitsmans M.H.P., Wolthaus J.W.H., Artignan X., et al. Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 623-635
23. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
24. Lawrence C, Zhou JL, Tits AL. User's guide for CFSQP version 2.5: a C code for solving (large scale) constrained nonlinear (minimax) optimization problems, generating iterates satisfying all inequality constraints, Institute for Systems Research, University of Maryland, Technical Report TR-94-16r1, College Park, MD 20742, 1997.
25. Noworolski S.M., Vigneron D.B., Chen A.P., and Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 26 (2008) 1071-1080
26. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
27. Padhani A.R., MacVicar A.D., Gapinski C.J., et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218 (2001) 365-374
28. Schabel C.M., and Parker D.L. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 53 (2008) 2345-2373
29. Zhang J., Rusinek H., Bokacheva L., Chen Q., Storey P., and Lee V. Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRI. J Magn Reson Imaging 30 (2009) 656-665
30. Parker G.J., Roberts C., Macdonald A., et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 56 (2006) 993-1000
31. Cheng H.L. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging 25 (2007) 1073-1078
32. Kershaw L.E., Hutchinson C.E., and Buckley D.L. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI. J Magn Reson Imaging 29 (2009) 641-648
33. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41 (1998) 501-510
34. Pickett B., Roach III M., Verhey L., et al. The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys 32 (1995) 211-218
35. Stroom J.C., and Storchi P.R. Automatic calculation of three-dimensional margins around treatment volumes in radiotherapy planning. Phys Med Biol 42 (1997) 745-755
36. Pinkawa M., Attieh C., Piroth M., et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous boost. Radiother Oncol 93 (2009) 213-219
37. Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 980-988
38. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
39. Pötter R., Haie-Meder C., van Limbergen E., et al. Recommendations from gynaecologycal (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brchytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
40. Bentzen S.M. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
41. Vos P.C., Hambrock T., Hulsbergen-van de Kaa C.A., Futterer J.J., Barentsz J.O., and Huisman H.J. Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. Med Phys 35 (2008) 888-899